Accustem Sciences Inc.
- Close
- Jan 14, 2026 · -17.65%
- Market cap
- $11.25M
- 16.07M shares
- Filings
- 77
Q2 2026
—Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
FY 2022derived
—Q2 2026N/M FY25 yoy
—
—
—- $11.25M
- —
- —
- —
- —
- —
FY2025 figures · derived
Price
Jan 14, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Pharmaceutical preparations
Accustem Sciences Inc. is the 418th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ONCOOnconetix, Inc.$815.4K67.7%1,721.0%$12.0MKAPAKairos Pharma, LTD.———$11.6MKPRXKiora Pharmaceuticals Inc$0.0100.0%—$11.6MCLRBCellectar Biosciences, Inc.———$11.6MVBIOValion Bio, Inc.———$11.3M
ACUTAccustem Sciences Inc. (this company)———$11.3M
HINDVyome Holdings, Inc$319.7K96.0%3,209.7%$11.1MLSTALisata Therapeutics, Inc.$170.0K83.0%9,756.5%$10.8MBFRGBullFrog AI Holdings, Inc.$116.7K—5,569.6%$10.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Accustem Sciences Inc. · CIK 1850767 · Engraved from SEC EDGAR